We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+10.88%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.12B
AUM Growth
+$596M
Cap. Flow
+$91.3M
Cap. Flow %
1.28%
Top 10 Hldgs %
11.77%
Holding
645
New
72
Increased
209
Reduced
241
Closed
76

Top Sells

Rank Stock Value
1
REVG
REV Group
REVG
+$46.8M
2
UNH icon
UnitedHealth
UNH
+$43.8M
3
AZEK
The AZEK Co
AZEK
+$23.3M
4
MCK icon
McKesson
MCK
+$21.1M
5
TJX icon
TJX Companies
TJX
+$17.8M

Sector Composition

Rank Sector Weight
1 Technology 20.65%
2 Industrials 18.36%
3 Financials 15.32%
4 Healthcare 12.69%
5 Consumer Discretionary 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIR icon
126
AAR Corp
AIR
$5.4B
$19.1M 0.27%
277,714
-1,337
-0.5% -$80.2K
VRTX icon
127
Vertex Pharmaceuticals
VRTX
$123B
$18.8M 0.26%
42,328
-10,494
-20% -$4.84M
CPRI icon
128
Capri Holdings
CPRI
$1.82B
$18.7M 0.26%
1,056,658
-177,033
-14% -$2.92M
RGEN icon
129
Repligen
RGEN
$6.91B
$18.5M 0.26%
148,599
+3,203
+2% +$408K
FIVN icon
130
FIVE9
FIVN
$2.08B
$18.4M 0.26%
695,749
-67,561
-9% -$1.76M
HUBG icon
131
HUB Group
HUBG
$2.92B
$18.4M 0.26%
550,979
-40,513
-7% -$1.36M
RDNT icon
132
RadNet
RDNT
$4.98B
$18.2M 0.26%
319,407
+54,364
+21% +$2.99M
SKWD icon
133
Skyward Specialty Insurance
SKWD
$2.53B
$18.2M 0.26%
314,395
+114,622
+57% +$6.61M
FLS icon
134
Flowserve
FLS
$8.94B
$18.1M 0.25%
+345,600
New +$16.3M
BOOT icon
135
Boot Barn
BOOT
$4.58B
$17.7M 0.25%
116,497
+37,876
+48% +$5.03M
FTI icon
136
TechnipFMC
FTI
$28.6B
$17.5M 0.25%
508,047
+87,129
+21% +$2.63M
BOX icon
137
Box
BOX
$4.49B
$17.5M 0.25%
511,920
+143,568
+39% +$4.71M
PCOR icon
138
Procore
PCOR
$7.57B
$17.5M 0.25%
255,630
+100,902
+65% +$6.59M
EXP icon
139
Eagle Materials
EXP
$6.49B
$17.4M 0.24%
86,172
+4,168
+5% +$898K
HQY icon
140
HealthEquity
HQY
$8.71B
$17.4M 0.24%
165,742
+65,151
+65% +$6.18M
NEO icon
141
NeoGenomics
NEO
$1.96B
$17.3M 0.24%
2,362,049
+11,303
+0.5% +$91.2K
BL icon
142
BlackLine
BL
$1.9B
$17.2M 0.24%
304,460
+28,562
+10% +$1.48M
CHE icon
143
Chemed
CHE
$7.16B
$17.2M 0.24%
35,237
+2,281
+7% +$1.3M
MTSI icon
144
MACOM Technology Solutions
MTSI
$17.4B
$17.1M 0.24%
119,513
+49,048
+70% +$5.73M
VIAV icon
145
Viavi Solutions
VIAV
$7.95B
$17M 0.24%
1,692,434
-39,793
-2% -$385K
BNY
146
Bank of New York Mellon
BNY
$103B
$17M 0.24%
187,029
-5,609
-3% -$476K
ALKS icon
147
Alkermes
ALKS
$8.11B
$17M 0.24%
593,938
+65,117
+12% +$1.94M
RMBS icon
148
Rambus
RMBS
$8.98B
$16.8M 0.24%
262,577
-23,185
-8% -$1.24M
WMT icon
149
Walmart Inc
WMT
$909B
$16.6M 0.23%
170,221
-4,696
-3% -$447K
VEA icon
150
Vanguard FTSE Developed Markets ETF
VEA
$223B
$16.3M 0.23%
+286,523
New +$15.3M

Similar funds

Segall Bryant & Hamill's Q2 2025 Portfolio in Review

As of Q2 2025, Segall Bryant & Hamill held 645 positions worth $7.12B, up 9.1% from $6.53B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill's Q2 2025 filing shows 72 new, 209 increased, 241 reduced and 76 closed positions. Its largest new stake was Flowserve: 345,600 shares worth $18.1M. The largest sale was REV Group, an estimated $46.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q2 2025 buy was Flowserve: 345,600 shares worth $18.1M.
  • Segall Bryant & Hamill added most to Meta Platforms (Facebook) in Q2 2025, an estimated $28.6M increase.
  • Segall Bryant & Hamill's biggest Q2 2025 reduction was REV Group, cutting an estimated $46.8M.
  • Segall Bryant & Hamill fully exited UnitedHealth in Q2 2025, selling an estimated $43.8M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $7.12B portfolio in Q2 2025.
  • Segall Bryant & Hamill opened 72 new positions and closed 76 in Q2 2025.
  • Segall Bryant & Hamill's portfolio value rose 9.1% quarter-over-quarter to $7.12B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2025, filed 12 Aug 2025.